Bülent Karakaya
Research Subjects
Research Interests
Bülent Karakaya has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Atilla Tutak
Department of İnternal Medicine, Adıyaman University of Medical Faculty, Adıyaman, Turkey
1 shared publication - Ayse Sahin Tutak
Adıyaman University, Turkey
1 shared publication - Cemaleddin Öztürk
Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Ankara University, Ankara, Turkiye
1 shared publication - Ekin Kırcalı
Ankara University Faculty of Medicine: Ankara Universitesi Tip Fakultesi
1 shared publication - Emir Dönder
Department of Internal Medicine, Faculty of Medicine, Fırat University, Elazığ 23119, Türkiye
1 shared publication - Erhan Onalan
Department of Internal Medicine, Faculty of Medicine, Fırat University, 23119 Elazig, Türkiye
1 shared publication
Latest Publications
- 19 August 2021
- Published by Bilimsel Tip Publishing House in LLM Dergi
- Vol. 5 (1) , 16-20
Allogeneic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: A Single Center Experience
- 19 August 2021
- Published by Bilimsel Tip Publishing House in LLM Dergi
- Vol. 5 (1) , 16-20
Allogeneic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: A Single Center Experience
- Open Access
- 1 January 2020
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 45 (2) , 680-687
Investigation of benfotiamine's protective effects on liver tissue in experimental carbon tetrachloride induced liver injury
Purpose: In this study, we aimed to investigate the protective effects of benfotiamine on experimental liver injury caused by carbon tetrachloride (CCl4). Materials and Methods: In this study, 30 male Wistar albino rats were used. Rats were equally divided into 5 groups. No application was made to control group. The CCl4 group was injected i.p with1ml/kg CCl4:olive oil (1:2) mixture on the 1st and 8th days, and the CCl4+benfotiamine group was treated i.p with 1 ml/kg CCl4: olive oil (1: 2) mixture twice on the 1st and 8th days and orally with 70 mg/kg/day benfotiamine. To the benfotiamine group, 70 mg/kg/day benfotiamine was given orally for 14 days. To the olive oil group, 2 ml/kg olive oil was given i.p. on 1st and 8th days. Finally, rats were decapitated. Liver tissues were removed and paraffin blocks were prepared. Tissues were stored at -80 oC for malonaldeyhde (MDA) assay. Results: There were no significant differences between the control, benfotiamine and olive oil groups. Compared with the control group, there was a significant increase in MDA, apoptosis and bax immunoreactivity in CCl4 group. Compared with the CCl4 group, there was a significant decrease in MDA, apoptosis and bax immunoreactivity in the CCl4+benfotiamine group. Conclusion: CCl4 increases MDA, apoptosis and bax immunoreactivity, and benfotiamine, given as treatment, reduces these parameters.
- 1 January 2020
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 45 (2) , 680-687
Open AccessInvestigation of benfotiamine's protective effects on liver tissue in experimental carbon tetrachloride induced liver injury
Purpose: In this study, we aimed to investigate the protective effects of benfotiamine on experimental liver injury caused by carbon tetrachloride (CCl4). Materials and Methods: In this study, 30 male Wistar albino rats were used. Rats were equally divided into 5 groups. No application was made to control group. The CCl4 group was injected i.p with1ml/kg CCl4:olive oil (1:2) mixture on the 1st and 8th days, and the CCl4+benfotiamine group was treated i.p with 1 ml/kg CCl4: olive oil (1: 2) mixture twice on the 1st and 8th days and orally with 70 mg/kg/day benfotiamine. To the benfotiamine group, 70 mg/kg/day benfotiamine was given orally for 14 days. To the olive oil group, 2 ml/kg olive oil was given i.p. on 1st and 8th days. Finally, rats were decapitated. Liver tissues were removed and paraffin blocks were prepared. Tissues were stored at -80 oC for malonaldeyhde (MDA) assay. Results: There were no significant differences between the control, benfotiamine and olive oil groups. Compared with the control group, there was a significant increase in MDA, apoptosis and bax immunoreactivity in CCl4 group. Compared with the CCl4 group, there was a significant decrease in MDA, apoptosis and bax immunoreactivity in the CCl4+benfotiamine group. Conclusion: CCl4 increases MDA, apoptosis and bax immunoreactivity, and benfotiamine, given as treatment, reduces these parameters.
- Open Access
- 1 January 2018
- Published by Fortune Journals in Archives of Clinical and Biomedical Research
- Vol. 02 (01) , 7-14
Should All Scorpion Stings be Followed Up in the Intensive Care Unit?
Should All Scorpion Stings be Followed Up in the Intensive Care Unit?, Archives of Clinical and Biomedical Research
- 1 January 2018
- Published by Fortune Journals in Archives of Clinical and Biomedical Research
- Vol. 02 (01) , 7-14
Open AccessShould All Scorpion Stings be Followed Up in the Intensive Care Unit?
Should All Scorpion Stings be Followed Up in the Intensive Care Unit?, Archives of Clinical and Biomedical Research